市场调查报告书
商品编码
1471990
血管成形术球囊市场规模和预测、全球和地区份额、趋势和成长机会分析报告范围:按类型、应用和最终用户Angioplasty Balloons Market Size and Forecast, Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type, Application, and End User |
根据我们关于「2030 年血管成形球囊市场预测 - 全球分析 - 类型、应用、最终用户和地理位置」的最新研究,2022 年市场估值为 27.1 亿美元,预计到 2030 年将达到 36 亿美元;预计2022年至2030年复合年增长率为3.6%。
血管成形术是一种用于拓宽狭窄或打开阻塞的冠状动脉并恢復血流的技术。基于价值的护理注重成本效益和患者治疗结果,正在改变医疗保健产业。与其他可用治疗方法相比,血管成形术球囊的市场将受到这些设备提供更好的患者治疗效果、降低血管重建率和更低成本的能力的影响。与传统的手术方法相比,血管成形术球囊提供了一种侵入性较小的治疗动脉阻塞的方法。
美洲 HEARTS 倡议由卫生部牵头,当地利益相关者参与,并得到泛美卫生组织 (PAHO) 的技术合作。该倡议正在该地区 22 个国家的 1,400 多个卫生中心实施。到 2025 年,HEARTS 将成为美洲初级卫生保健中心血管风险管理的典范,其中包括高血压、糖尿病和血脂异常等疾病。
此外,在欧洲,医疗保健公共支出的成长速度快于国内支出,但主要是在高收入国家。欧盟委员会的EU4Health 计划、下一代復苏基金和Horizon Europe 研究基金提供了一个机会,透过实施欧盟行动计划中确定的改善心血管健康的预防措施,解决心血管疾病的负担并改善公民的心血管健康。该计划涵盖了整个患者旅程,从预防和早期检测到获得护理和治疗,再到生活品质和功能状态,考虑到数位化和创新在各个阶段的重要作用。因此,增加医疗保健支出和政府主导的有关心臟健康的措施将为血管成形术球囊市场创造成长机会。
按类型划分,基于血管成形术球囊市场的见解
根据类型,血管成形术球囊市场分为普通球囊、药物洗脱球囊、切割球囊和评分球囊。 2022 年,普通球囊细分市场占据最大的血管成形球囊市场。在血管内治疗中,药物涂层球囊(DCB)(主要是紫杉醇涂层球囊)被更频繁地使用,以改善血管成形术的低通畅性结果。在解决血液透析通路功能障碍时,从短期来看,使用药物洗脱球囊可能比简单的球囊血管成形术需要更少的再介入和相关的医疗费用。
按最终用户,基于血管成形术球囊市场的见解
血管成形术球囊市场,依最终使用者、医院、门诊手术中心等划分。医院细分市场在 2022 年占据最大的血管成形球囊市场份额,并且由于住院时间要求最短和先进服务的可用性,预计 2022 年至 2030 年复合年增长率最高。此外,在门诊手术中心进行的治疗具有成本效益,这有助于降低总医疗费用。所有这些因素都促进了门诊手术中心领域的成长。
世界心臟联合会欧洲学会和世界卫生组织是在准备血管成形术球囊市场报告时提到的一些主要二手来源。
註 - 将为以下提到的地区/国家提供类似的分析
According to our latest study on " Angioplasty Balloons Market Forecast to 2030 - Global Analysis -Type, Application, End User, and Geography," the market was valued at US$ 2.71 billion in 2022 and is expected to reach US$ 3.60 billion by 2030; it is estimated to register a CAGR of 3.6% from 2022 to 2030.
An angioplasty is a technique used to widen narrowed or open clogged coronary arteries and restore blood flow. Value-based care, which focuses on cost-effectiveness and patient outcomes, is changing the healthcare sector. The market for angioplasty balloons will be influenced by the capacity of these devices to provide better patient outcomes, reduced revascularization rates, and lower costs compared to other available treatments. Compared to conventional surgical methods, angioplasty balloons provide a less invasive method of treating clogged arteries.
The initiative HEARTS in the Americas is led by the Ministries of Health with the participation of local stakeholders and the technical cooperation of the Pan American Health Organization (PAHO). The Initiative is being executed in more than 1,400 health centers in 22 nations across the region. By 2025, HEARTS will be the model for cardiovascular risk management, which includes diseases such as hypertension, diabetes, and dyslipidemia, in primary health care in the Americas.
Moreover, in Europe, public spending on healthcare has grown faster than domestic spending, but mainly in high-income countries. The European Commission's EU4Health program, the Next Generation Recovery Funds, and the Horizon Europe Research Funds offer an opportunity to address the burden of cardiovascular diseases and improve the cardiovascular health of citizens by implementing preventative measures identified in an EU Action Plan for better cardiovascular health. This plan covers the overall patient journey, from prevention and early detection to access to care and treatment to quality of life and functioning status, considering the vital role of digitization and innovation at all stages. Thus, increasing healthcare spending and government-led initiatives regarding heart health to create growth opportunity in angioplasty balloons market.
By Type, Angioplasty Balloons Market-Based Insights
Based on type, the angioplasty balloons market is segmented into normal balloons, drug eluting balloons, cutting balloons, and scoring balloons. The normal balloons segment held the largest angioplasty balloons market share in 2022. However, the drug eluting balloons segment is anticipated to register the highest CAGR during 2022-2030. In endovascular therapy, drug-coated balloons (DCB), primarily paclitaxel-coated balloons, are being utilized more frequently to improve the low patency results of angioplasty. When addressing hemodialysis access dysfunction, the use of drug-eluting balloons might, in the short run, require less reintervention and associated healthcare costs than simple balloon angioplasty.
By End User, Angioplasty Balloons Market-Based Insights
The angioplasty balloons market, by end user, hospitals, ambulatory surgery centers, and others. The hospitals segment held the largest angioplasty balloons market share in 2022 and is anticipated to register the highest CAGR during 2022-2030, owing to the minimum hospital stay requirements and the availability of advanced services. In addition, treatments performed in ambulatory surgery centers are cost-effective, which helps cut down on total medical costs. All these factors contribute to the growth of the ambulatory surgery center segment.
European Society of World Heart Federation, and the World Health Organization, are a few of the major secondary sources referred to while preparing the report on the angioplasty balloons market.
Note - Similar analysis would be provided for below mentioned regions/countries
Note - Similar information would be provided for below list of companies